57
Participants
Start Date
December 28, 2012
Primary Completion Date
May 13, 2016
Study Completion Date
July 17, 2018
S-1
S-1 is administered orally at a dose of 40 mg/m2 twice daily on the day of irradiation (Monday through Friday) during radiation therapy.
Radiation Therapy
Radiation therapy is delivered with \>6-megavolts (MV) photons, using a multiple field technique. A total dose of 50.4 Gy is delivered in 28 fractions over 5.5 weeks.
Aichi Cancer Center, Nagoya
Nagoya University Hospital, Nagoya
Hirosaki University Hospital, Hirosaki
National Cancer Center Hospital East, Kashiwa
Shikoku Cancer Center, Matsuyama
Fukuyama City Hospital, Fukuyama
National Hospital Organization Kure Medical Center, Kure
Asahikawa Medical University, Asahikawa
Hokkaido University Hospital, Sapporo
Kobe University Hospital, Kobe
St. Marianna University School of Medicine Hospital, Kawasaki
Kanagawa Cancer Center, Yokohama
National Hospital Organization Osaka National Hospital, Chuo-ku
Saitama Cancer Center, Kita-adachigun Inamachi
Seirei Mikatahara General Hospital, Hamamatsu
Shizuoka Cancer Center, Suntohgun, Nagaizumityo
Jichi Medical University Hospital, Shimotsuke
Tochigi Cancer Center, Utsunomiya
Tokyo Women's Medical University Hospital, Shinjuku
Chiba Cancer Center, Chiba
National Hospital Organization Kyusyu Cancer Center, Fukuoka
Yamagata University Hospital, Yamagata
Japan Agency for Medical Research and Development
OTHER_GOV
Pharma Valley Center
UNKNOWN
Japan Adjuvant Study Group of Pancreatic Cancer
OTHER